Lidocaine Patch
Product Images NDC 59088-396

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 59088-396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puretek Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (New Label)

Lidocaine Patch 5% (50 mg/g) topical adhesive patch packaging label from PureTek Corporation. The label indicates each patch contains lidocaine 700 mg, with inactive components listed. The package contains 30 patches in 30 individual envelopes. Directions for use include removing the patch from the envelope and applying it to the skin, with warnings to keep patches away from children and pets. The label also notes storage instructions and manufacturer details for Actavis Laboratories UT, Inc.*

FDA Label Image

Image Description (Figure 1)

A line graph depicting plasma lidocaine concentration (ng/mL) over time (hours) up to 72 hours. The plot shows three distinct peaks in plasma lidocaine levels occurring approximately every 24 hours, with concentrations rising and falling in a repeating cyclical pattern.*

FDA Label Image

Image Description (Lidocaine Structure)

Chemical structure diagram of Lidocaine, showing its molecular arrangement including aromatic ring, amide bond, and diethylamino group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.